The Food and Drugs Authority (FDA) has revoked the marketing authorization for Omama Herbal Mixture after laboratory tests revealed that the product had been adulterated with prescription medicines.
In a statement dated October 31, the FDA said a joint market surveillance operation conducted in collaboration with the Ghana Police Service uncovered that the herbal product contained Diazepam, Metronidazole, Paracetamol, and Niacinamide—all classified as allopathic medicines.
The FDA emphasized that Omama Herbal Mixture was registered as a herbal medicinal product indicated for the treatment of malaria and loss of appetite and was not expected to contain any synthetic or prescription medications.
“The medicines found in Omama Herbal Mixture are dangerous when taken without prescription or advice from a qualified health professional,” the Authority warned.
The FDA cautioned the public against patronizing the product, advising consumers to immediately stop using it and report any pharmacy, herbal shop, or over-the-counter medicine seller still offering it for sale.
Meanwhile, the FDA is working with Omama Herbal Group Limited to recall all affected products from the market for safe disposal. It also noted that appropriate regulatory and legal actions, including criminal prosecution, are being initiated against the company.
The Authority reaffirmed its commitment to safeguarding public health and urged consumers to report anyone distributing Omama Herbal Mixture to the nearest FDA office.
“The FDA wishes to assure the public that it will not relent in its effort to ensure public health and safety,” the statement concluded.
